Defective repair of cartilage matrix is a major feature accounting for loss of function of articular cartilage in osteoarthritis (OA) and other arthritides. In the past, definition of the mechanisms that induce and maintain anabolic activities in human chondrocytes have been hampered by the lack of suitable chondrocyte culture systems. Recently, we reported the development and characterization of immortalized human chondrocyte lines that express cartilage-specific matrix proteins under defined culture conditions. In this proposal, a newly established temperature-sensitive articular chondrocyte line (tsT/AC62) will be used to define at the cellular and molecular level the mechanisms involved in the induction and maintenance of """"""""appropriate"""""""" patterns of synthesis of cartilage-specific collagen, and other matrix proteins. It is our hypothesis that down-regulation of proliferation and maintenance in a 3-dimensional environment in the presence of critical anabolic factors will permit expression of the chondrocyte phenotype and matrix deposition in vitro and in vivo. Our approach will be to develop 3- dimensional culture models in which the chondrocyte phenotype is enhanced and maintained in vitro and identify critical factors controlling cartilage-specific gene expression and matrix synthesis both in vitro and in vivo by the following specific aims: (1) Determine factors that maintain and enhance chondrocyte phenotype in immortalized human chondrocyte culture models in vitro. (2) Identify molecular mechanisms involved in induction and maintenance of differentiated chondrocyte phenotype by direct analysis of regulatory sequences of the cartilage-specific type II collagen gene (COL2A1). (3) Examine factors influencing cartilage formation in vivo. Implantation of genetically engineered human chondrocytes in a three-dimensional collagen matrix in SCID mice will validate the results obtained in vitro and test the capacity of these cells to participate in authentic cartilage repair. The availability of human chondrocyte culture models that can be manipulated reproducibly to undergo defined programs of differentiation will allow us to examine in greater detail the molecular mechanisms regulating COL2A1 expression both in vitro and in vivo. An understanding of critical signals that induce and maintain chondrocyte phenotype, but that may not be present in the microenvironment of the adult OA chondrocyte, will eventually provide rational strategies for ex vivo gene therapy for improving cartilage repair with chondrocyte transplantation approaches.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR045378-03
Application #
6171759
Study Section
Oral Biology and Medicine Subcommittee 1 (OBM)
Program Officer
Tyree, Bernadette
Project Start
1998-07-10
Project End
2002-06-30
Budget Start
2000-07-01
Budget End
2001-06-30
Support Year
3
Fiscal Year
2000
Total Cost
$331,005
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
Otero, Miguel; Favero, Marta; Dragomir, Cecilia et al. (2012) Human chondrocyte cultures as models of cartilage-specific gene regulation. Methods Mol Biol 806:301-36
Peng, Haibing; Tan, Lujian; Osaki, Makoto et al. (2008) ESE-1 is a potent repressor of type II collagen gene (COL2A1) transcription in human chondrocytes. J Cell Physiol 215:562-73
Goldring, Mary B; Goldring, Steven R (2007) Osteoarthritis. J Cell Physiol 213:626-34
Zhou, Y; Millward-Sadler, S J; Lin, H et al. (2007) Evidence for JNK-dependent up-regulation of proteoglycan synthesis and for activation of JNK1 following cyclical mechanical stimulation in a human chondrocyte culture model. Osteoarthritis Cartilage 15:884-93
Pufe, T; Groth, G; Goldring, M B et al. (2007) Effects of pleiotrophin, a heparin-binding growth factor, on human primary and immortalized chondrocytes. Osteoarthritis Cartilage 15:155-62
Goldring, Mary B (2006) Update on the biology of the chondrocyte and new approaches to treating cartilage diseases. Best Pract Res Clin Rheumatol 20:1003-25
Varoga, D; Paulsen, F; Mentlein, R et al. (2006) TLR-2-mediated induction of vascular endothelial growth factor (VEGF) in cartilage in septic joint disease. J Pathol 210:315-24
Ijiri, Kosei; Zerbini, Luiz F; Peng, Haibing et al. (2005) A novel role for GADD45beta as a mediator of MMP-13 gene expression during chondrocyte terminal differentiation. J Biol Chem 280:38544-55
Caminos, J E; Gualillo, O; Lago, F et al. (2005) The endogenous growth hormone secretagogue (ghrelin) is synthesized and secreted by chondrocytes. Endocrinology 146:1285-92
Varoga, Deike; Pufe, Thomas; Harder, Jurgen et al. (2005) Human beta-defensin 3 mediates tissue remodeling processes in articular cartilage by increasing levels of metalloproteinases and reducing levels of their endogenous inhibitors. Arthritis Rheum 52:1736-45

Showing the most recent 10 out of 41 publications